Tracerlab: Scientific collaboration

We, as Tracerlab, are looking to collaborate with medical researchers, preferably educational institutions, who are looking for the synthetic development and initial in vitro validation of PET/optical/MRI tracers.

App screenshot

Collaborate with medical researchers, who are looking for the synthetic development and initial in vitro validation of PET/optical/MRI tracers.

What we're looking for

We, as Tracerlab, are looking to collaborate with medical researchers, preferably educational institutions, who are looking for the synthetic development and initial in vitro validation of PET/optical/MRI tracers. Typically, we’re looking to collaborate with someone who is looking to visualize a process/receptor/enzyme/etc, knows from literature a good chemical entity that could be used (enzyme inhibitor, receptor ligand, etc.) but has no idea how to make it and then modify it towards an imaging modality. Sometimes, this person is uncertain what imaging modality to use and we can help.

We’re not just looking to collaborate with medical researchers, but also with preclinical scientists looking for collaboration and students interested in BSc, MSc and PhD programs.

Ready to collaborate? Contact us today!

Contact us

Who are we

Expertise & Facilities

FFC Relaxometry: T1 NMRD profile acquisition using Stelar SMARtracer equipment

Contact us
Smart Tracer

Meet the team

See who's involved with Tracerlab right now and who's been involved in the past.

  • Photo of Hugo Helbert, MsC

    Hugo Helbert, MsC

    Current member

  • Photo of Ilse Welleman, MsC

    Ilse Welleman, MsC

    Current member

  • Photo of Verena I. Boehmer, PhD

    Verena I. Boehmer, PhD

    Past member

  • Photo of Friederike Reeßing, PhD

    Friederike Reeßing, PhD

    Past member

Ready to collaborate? Contact us today!

Contact us

Publications

Cross-coupling of [<sup>11</sup>C]methyllithium for <sup>11</sup>C-labelled PET tracer synthesis

Chem. Comm. 2021, 57, 203-206

Cross-coupling of [11C]methyllithium for 11C-labelled PET tracer synthesis

Hugo Helbert, Inês Farinha Antunes, Gert Luurtsema, Wiktor Szymanski, Ben L. Feringa,* Philip H. Elsinga*
Multivalent Probes in Molecular Imaging: Reality or Future?

Trends Mol. Med. 2021, ASAP

Multivalent Probes in Molecular Imaging: Reality or Future?

Verena I. Boehmer, Wiktor Szymanski, Ben L. Feringa, Philip H. Elsinga*
A Photocleavable Contrast Agent for Light-Responsive MRI

Pharmaceuticals 2020, 13, 296

A Photocleavable Contrast Agent for Light-Responsive MRI

Friederike Reeßing, Sèvrin E. M. Huijsse, Rudi A. J. O. Dierckx, Ben L. Feringa, Ronald J.H. Borra and Wiktor Szymanski*
A Facile and Reproducible Synthesis of Near-Infrared Fluorescent Conjugates with Small Targeting Molecules for Microbial Infection Imaging

ACS Omega 2020, 5, 22071-22080

A Facile and Reproducible Synthesis of Near-Infrared Fluorescent Conjugates with Small Targeting Molecules for Microbial Infection Imaging

Friederike Reeßing, Mafalda Bispo, Marina López-Álvarez, Marleen van Oosten, Ben L. Feringa, Jan Maarten van Dijl, Wiktor Szymanski*
Modular Medical Imaging Agents Based on Azide–Alkyne Huisgen Cycloadditions: Synthesis and Pre‐Clinical Evaluation of 18F‐Labeled PSMA‐Tracers for Prostate Cancer Imaging

Chem. Eur. J. 2020, 26, 10871 –10881

Modular Medical Imaging Agents Based on Azide–Alkyne Huisgen Cycloadditions: Synthesis and Pre‐Clinical Evaluation of 18F‐Labeled PSMA‐Tracers for Prostate Cancer Imaging

Verena I. Böhmer, Wiktor Szymanski,* Keimpe-Oeds van den Berg, Chantal Mulder, Piermichele Kobauri, Hugo Helbert, Dion van den Born, Friederike Reessing, Anja Huizing,…, Gert Luurtsema, Wijnand Helfrich, Ton J. Visser, Ben L. Feringa,* Philip H. Elsinga*
A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery

ChemComm 2019, 55, 10784-10787

A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery

Friederike Reeßing, Mark C.A. Stuart, Douwe F. Samplonius, Rudi A.J.O. Dierckx, Ben L. Feringa, Wijnand Helfrich, Wiktor Szymanski*
Following nanomedicine activation with magnetic resonance imaging: why, how, and what’s next?

Curr. Opin. Biotech. 2019, 58, 9-18

Following nanomedicine activation with magnetic resonance imaging: why, how, and what’s next?

Friederike Reeßing, Wiktor Szymanski*
Oxygen Activated, Palladium Nanoparticle Catalyzed, Ultrafast Cross‐Coupling of Organolithium Reagents

Angew. Chem. Int. Ed. 2017, 56, 3354–3359

Oxygen Activated, Palladium Nanoparticle Catalyzed, Ultrafast Cross‐Coupling of Organolithium Reagents

Dorus Heijnen, Filippo Tosi, Carlos Vila, Marc C. A. Stuart, Philip H. Elsinga, Wiktor Szymanski and Ben L. Feringa*
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin

Angew. Chem. Int. Ed. 2011, 50, 11117-11120

Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin

Lachlan S. Campbell‐Verduyn, Leila Mirfeizi, Anne K. Schoonen, Prof. Dr. Rudi A. Dierckx, Prof. Dr. Philip H. Elsinga, Prof. Dr. Ben L. Feringa
Phosphoramidite accelerated copper(i)-catalyzed [3 + 2] cycloadditions of azides and alkynes

ChemComm 2009, 2139-2141

Phosphoramidite accelerated copper(i)-catalyzed [3 + 2] cycloadditions of azides and alkynes

Lachlan S. Campbell-Verduyn, Leila Mirfeizi, Rudi A. Dierckx, Philip H. Elsinga* and Ben L. Feringa*